By Habtamu W. Liben
ADDIS ABABA Oct. 27 (EI) — Experts from Eastern and Southern Africa have launched a comprehensive five-day assessment of Ethiopia’s Quality Control Laboratory to evaluate its readiness for designation as a Regional Reference Laboratory, aiming to strengthen health product regulation, bolster continuous quality assurance, and expand reliable access across participating nations.
This came as the Intergovernmental Authority on Development (IGAD) convened the exercise in Addis Ababa from October 26 to 30, bringing together technical representatives from national quality control laboratories under the World Bank-supported Health Emergency Preparedness, Response and Resilience program to examine technical and operational capabilities.
Attaining Maturity Level 3 under the World Health Organization’s Global Benchmarking Tool and ISO/IEC 17025:2017 accreditation positions the Ethiopian facility as a leading candidate, while the current assessment focuses on institutional governance, workforce competencies, analytical testing capacities, and data integrity standards.
Technical specialists from Burundi, Kenya, Malawi, Rwanda, and Zambia are conducting document reviews, facility inspections, and practical evaluations using an adapted Stepwise Assessment Tool Towards Accreditation to identify capacity gaps and guide priority investments before establishing the regional mandate.
Addressing the five-day gathering, Heran Gerba, Director General of Ethiopian Food and Drug Authority, expressed commended the IGAD Secretariat and the World Bank for supporting regulatory system strengthening, emphasizing that access to safe, quality-assured medical products represents a foundational pillar for building resilient public health systems across the African continent.

Gerba highlighted that government policy directions and substantial capital investments enabled the authority to attain Maturity Level 3 status, while the ongoing construction of a specialized Centre of Excellence represents another major commitment toward advancing continental regulatory affairs, testing capabilities, and workforce training.
She noted that evolving global technologies require highly capacitated regulators capable of evaluating complex products like vaccines and biologicals, underscoring that collaboration with regional economic communities and the African Medicines Agency remains essential to address cross-border circulation of substandard and falsified health products.
The Director General reaffirmed that the authority views the readiness assessment as a valuable continuous improvement opportunity, welcoming constructive partner feedback to refine testing practices, support local pharmaceutical manufacturers, and accelerate research while maintaining rigorous regulatory oversight throughout the vast regional market.
Echoing the sentiment, IGAD Director of Health and Social Development, Amb. Moussa Meigague, emphasized that establishing connected regional quality-assurance systems generates crucial scientific evidence for regulatory decisions, enhances post-market surveillance, and enables member states to respond more effectively to routine and emergency health requirements.
Meigague pointed out that limited specialized testing capabilities and fragmented national laboratory systems across the region often create operational bottlenecks, making shared frameworks and trusted referral arrangements vital for improving testing efficiency, comparability, and confidence in cross-border regulatory actions.
He stressed that while WHO Maturity Level 3 and ISO accreditation provide a solid foundation, the assessment team must rigorously apply agreed methodologies to examine operational readiness, evaluate technical risks, and formulate prioritized operationalization roadmaps based on regional ownership, scientific integrity, and non-duplication.
The Director further urged participating regulatory authorities and laboratory managers to engage candidly throughout the appraisal process, ensuring that the final operational roadmap, gap analysis matrix, and sustainability mechanisms align precisely with the practical needs of participating Eastern and Southern African countries.
The technical evaluation is expected to culminate in a comprehensive scorecard, risk mitigation matrix, and operationalization plan detailing specific timelines, institutional responsibilities, and resource requirements needed to guide formal regional advisory committee recognition and laboratory operationalization.
Once fully operationalized, the reference facility will deliver specialized testing services, coordinate inter-laboratory proficiency testing, facilitate cross-border sample referrals, and support continuous professional development to help participating laboratories progress toward higher global benchmarking standards and accreditation levels, it was noted.
Ultimately, the coordinated initiative envisages to build robust laboratory networks, foster regulatory reliance, and harmonize standards across participating nations, directly contributing to enhanced public health protection and sustainable access to safe, effective, and quality-assured medical technologies.



















